ABSOLUTE: A phase 3 trial of nanoparticle albumin-bound paclitaxel (nab-PTX) versus solvent-based paclitaxel (sb-PTX) in patients with pre-treated advanced gastric cancer (AGC)—Efficacy and QOL results.

Keisuke Koeda,Kohei Shitara,Atsuo Takashima,Kazumasa Fujitani,Hironori Tsujimoto,Akihito Tsuji,Eiji Oki,Akinori Takagane,Masakazu Takagi,Yasuo Hamamoto,Hideo Baba,Yasushi Omuro,Hiroyuki Okuda,Yasuyuki Nakano,Naotoshi Sugimoto,Michio Nakamura,Kazuhiro Imamura,Daisuke Ichikawa,Hiroyuki Kuwano,Wasaburo Koizumi

ABSOLUTE: A phase 3 trial of nanoparticle albumin-bound paclitaxel (nab-PTX) versus solvent-based paclitaxel (sb-PTX) in patients with pre-treated advanced gastric cancer (AGC)—Efficacy and QOL results.

2017

4010Background: Sb-PTX is a standard second-line treatment for patients (pts) with AGC. Nab-PTX was developed to avoid the toxicities with use of solvents in sb-PTX and potentially improve efficacy...

Keywords:

Cancer
Cancer research
Physical therapy
Paclitaxel
Medicine
Albumin
solvent based
in patient
Oncology
albumin bound paclitaxel
Internal medicine
Pathology
advanced gastric cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations